Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study

Cancer Cell · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles